Oncolytics Biotech Inc. (ONCY) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Oncolytics Biotech Inc.

    NASDAQ: ONCY · Real-Time Price · USD
    1.38
    -0.04 (-2.82%)
    At close: Oct 03, 2025, 3:59 PM
    1.44
    4.35%
    After-hours: Oct 03, 2025, 05:54 PM EDT

    Oncolytics Biotech Income Statement

    Financials in CAD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a 403K 392K 452.06K
    Gross Profit
    		 n/a -403K -392K -452.06K
    Operating Income
    		 -34.98M -33.79M -28.57M -26.23M
    Interest Income
    		 n/a 1.33M 528K 98.61K
    Pretax Income
    		 -31.58M -27.66M -24.75M -26.25M
    Net Income
    		 -31.71M -27.75M -24.84M -26.3M
    Selling & General & Admin
    		 13.34M 16.08M 11.49M 12.86M
    Research & Development
    		 21.65M 17.71M 15.43M 12.92M
    Other Expenses
    		 n/a n/a n/a 13.31M
    Operating Expenses
    		 34.98M 33.79M 26.92M 26.23M
    Interest Expense
    		 n/a n/a 528K n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a -452.49K
    Cost & Expenses
    		 34.98M 33.79M 26.92M 26.23M
    Income Tax Expense
    		 130K 97K 84K 49.43K
    Shares Outstanding (Basic)
    		 76.48M 67.62M 58.03M 53.51M
    Shares Outstanding (Diluted)
    		 76.48M 67.62M 58.03M 53.51M
    EPS (Basic)
    		 -0.41 -0.41 -0.43 -0.49
    EPS (Diluted)
    		 -0.41 -0.41 -0.43 -0.49
    EBITDA
    		 -34.88M -33.71M -26.83M -25.66M
    EBIT
    		 -34.98M -33.79M -26.92M -26.23M
    Depreciation & Amortization
    		 102K 81K 392K 452.06K

    Add to Watchlist